Abstract:The majority of invasive human fungal pathogens gain access to their human hosts via the inhalation of spores from the environment into the lung, but relatively little is known about this infectious process. Among human fungal pathogens the most frequent cause of inhaled fatal fungal disease is Cryptococcus, which can disseminate from the lungs to other tissues, including the brain, where it causes meningoencephalitis. To determine the mechanisms by which distinct infectious particles of Cryptococcus cause disseminated disease, we evaluated two developmental cell types (spores and yeast) in mouse models of infection. We discovered that while both yeast and spores from several strains cause fatal disease, there was a consistently higher fungal burden in the brains of spore-infected mice. To determine the basis for this difference, we compared the pathogenesis of avirulent yeast strains with their spore progeny derived from sexual crosses. Strikingly, we discovered that spores produced by avirulent yeast caused uniformly fatal disease in the murine inhalation model of infection. We determined that this difference in outcome is associated with the preferential dissemination of spores to the lymph system. Specifically, mice infected with spores harbored Cryptococcus in their lung draining lymph nodes as early as one day after infection, whereas mice infected with yeast did not. Furthermore, phagocyte depletion experiments revealed this dissemination to the lymph nodes to be dependent on CD11c+ phagocytes, indicating a critical role for host immune cells in preferential spore trafficking. Taken together, these data support a model in which spores capitalize on phagocytosis by immune cells to escape the lung and gain access to other tissues, such as the central nervous system, to cause fatal disease. These previously unrealized insights into early interactions between pathogenic fungal spores and lung phagocytes provide new opportunities for understanding cryptococcosis and other spore-mediated fungal diseases.Little is known about how inhaled spores from human fungal pathogens cause infections and spread to other parts of the body. The most frequent cause of inhaled fatal fungal disease is Cryptococcus, which causes meningitis. To understand how Cryptococcus causes disease, we evaluated pathogenesis of two types of cells (spores and yeast) in a mouse model of infection. We compared yeast strains that cannot cause disease to the spore offspring they produced during sexual reproduction. We discovered that parental yeast that are not virulent produced spores that were fully virulent and caused fatal meningitis. This difference was associated with movement of spores to the lymph system; mice infected with spores had Cryptococcus in their lung draining lymph nodes, but mice infected with yeast did not. Furthermore, when we infected mice that lacked immune cells in their lungs, no spores were found in their lymph nodes. This indicates that instead of protecting mice from the spore infection, the immune cells moved spores out of the lung to the lymph system where spores could then spread to the brain. These insights into interactions between pathogenic fungal spores and lung immune cells provide new opportunities for understanding cryptococcosis and other spore-mediated fungal diseases.

Lack of an atypical PDR transporter generates an immunogenic strain that drives a dysregulated and lethal immune response in murine lungs

An Atypical ABC Transporter Is Involved in Antifungal Resistance and Host Interactions in the Pathogenic Fungus Cryptococcus neoformans

Mutations of Charged Amino Acids at the Cytoplasmic End of Transmembrane Helix 2 Affect Transport Activity of the Budding Yeast Multidrug Resistance Protein Pdr5p.

Polyphosphate mobilization influences the ability of Cryptococcus neoformans to cause disease in a murine model of cryptococcosis

Antagonistic Changes in Sensitivity to Antifungal Drugs by Mutations of an Important ABC Transporter Gene in a Fungal Pathogen

Redefining pleiotropic drug resistance in a pathogenic yeast: Pdr1 functions as a sensor of cellular stresses in Candida glabrata

What makes pan-drug resistant? Integrative insights from genomic, transcriptomic, and phenomic analysis of clinical strains resistant to all four major classes of antifungal drugs

The mouse lung early cellular innate immune response is not sufficient to control fungal infection with Cryptococcus neoformans

Host-Pathogen Interactions Mediated by MDR Transporters in Fungi: As Pleiotropic as it Gets!

CgPDR1 Gain-of-function Mutations Lead to Azole-Resistance and Increased Adhesion in Clinical Candida Glabrata Strains

Characterization of Three Pleiotropic Drug Resistance Transporter Genes and Their Participation in the Azole Resistance of Mucor circinelloides

Transcriptional Profiling of Patient Isolates Identifies a Novel TOR/Starvation Regulatory Pathway in Cryptococcal Virulence

Infectious particle identity determines dissemination and disease outcome for the inhaled human fungal pathogen Cryptococcus

Pleiotropy and epistasis within and between signaling pathways defines the genetic architecture of fungal virulence

Defects in intracellular trafficking of fungal cell wall synthases lead to aberrant host immune recognition

Cryptococcus neoformans trehalose-6-phosphate synthase (tps1) promotes organ-specific virulence and fungal protection against multiple lines of host defenses

Extracellular vesicles from Pneumocystis carinii-infected rats impair fungal viability but are dispensable for macrophage functions

Sac1 links phosphoinositide turnover to cryptococcal virulence

Innate Immunity against Cryptococcus, from Recognition to Elimination

Loss of the putative Rab GTPase, Ypt7, impairs the virulence of Cryptococcus neoformans

A mutation in C. neoformans mitochondrial NADH dehydrogenase results in increased virulence in mice